JPRN-jRCTs051180229
Recruiting
未知
ALS biomarker research using patient clinical samples
Inoue Haruhisa0 sites49 target enrollmentMarch 30, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- amyotrophic lateral sclerosis (ALS)
- Sponsor
- Inoue Haruhisa
- Enrollment
- 49
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Those who agree to attend the current clinical study among ALS patients joining an accompanying clinical trial Phase 1/2 Dose Escalation Study of Bostinib in Patients with Amyotrophic Lateral Sclerosis (ALS)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
ASSESS ALL ALS StudyAmyotrophic Lateral SclerosisNCT06578195St. Joseph's Hospital and Medical Center, Phoenix2,000
Recruiting
Not Applicable
A Longitudinal Analysis of Biomarkers in Patients With ALSAmyotrophic Lateral SclerosisNCT05309408Holy Cross Hospital, Florida90
Completed
Not Applicable
Disease biomarkers in amyotrophic lateral sclerosis/motor neuron diseaseISRCTN28270972Barts and The London NHS Trust (UK)100
Not yet recruiting
Not Applicable
Amyotrophic Lateral Sclerosis RegistryAmyotrophic Lateral SclerosisNCT05892822yilong Wang1,000
Recruiting
Not Applicable
PREVENT ALL ALS StudyAmyotrophic Lateral SclerosisNCT06581861St. Joseph's Hospital and Medical Center, Phoenix600